Periodic Reporting for period 1 - Myco_Metabolism (How iron and manganese affect the central metabolism in pathogenic mycobacteria)
Reporting period: 2021-06-15 to 2023-06-14
This project investigated the effects of iron deficiency and high manganese concentrations on the metabolism of Mycobacterium tuberculosis and Mycobacterium abscessus, two unicellular pathogenic organisms that cause lung infections. This study reveals new aspects of the physiology of two pathogenic bacteria that are highly tolerant to antibiotics. Infections caused by M. tuberculosis and M. abscessus are difficult to treat precisely because of this high tolerance. Treatment lasts from six months to two years, and is accompanied by the obvious side effects of the drugs due to the extensive therapy. M. abscessus is of a particular clinical concern as it is more tolerant than M. tuberculosis. While there are international guidelines from the WHO for the latter, M. abscessus infections are dealt with on a case-by-case basis. The nutritional conditions used in this research define a metabolic state of the bacterial cell that has never before been used to study antibiotic resistance. Such conditions may provide a new screening platform to identify new drugs or to improve existing therapies, and are applicable to all pathogenic microorganisms, not just mycobacteria.
The results of this project were presented in two international conferences focused on mycobacterial research EMBO Workshop on Tuberculosis 2022 (12th-16th September 2022, Paris, France) and 42nd European Society of Mycobacteriology Congress 2022 (26th-29th June, Bologna, Italy).
This project paved the way for understanding the mechanisms of adaptation of highly antibiotic-tolerant bacteria, such as Mycobacterium tuberculosis and Mycobacterium abscessus, to changes in metal availability in different metabolic states.
In this project, it was seen that specific alterations in energy metabolism occur in response to iron deficiency. No specific alterations in central metabolism in response to exposure to sub-inhibitory concentrations of manganese were identified, but alterations related to the translation apparatus were clear.
The nutritional conditions used in this research define a metabolic state of the bacterial cell that has never before been used for antibiotic resistance investigations. Such conditions may provide a new screening platform to identify new drugs or to improve existing therapies, and is applicable to all pathogenic microorganisms, not just mycobacteria. Given the spread of antibiotic resistance, the development of new medicines is urgently needed. And given the functional relevance of metabolism in mediating antibiotic resistance, diversifying screening programmes to test drugs (i.e. compound libraries) on bacteria in differentiated metabolic states defined by two nutrient variants, such as metal ion and carbon source, could represent a valid new way to develop novel antibacterial treatments.